Interpace Biosciences, Inc. (IDXG)
OTCMKTS
· Delayed Price · Currency is USD
1.280
+0.210 (19.63%)
Apr 10, 2025, 3:34 PM EDT
Interpace Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 1.46 | 3.5 | 4.83 | 2.67 | 2.77 | Upgrade
|
| Cash & Short-Term Investments | 1.46 | 3.5 | 4.83 | 2.67 | 2.77 | Upgrade
|
| Cash Growth | -58.23% | -27.55% | 80.69% | -3.61% | 19.43% | Upgrade
|
| Accounts Receivable | 8.54 | 5.08 | 5.03 | 4.67 | 8.03 | Upgrade
|
| Receivables | 8.54 | 5.08 | 5.03 | 4.67 | 8.03 | Upgrade
|
| Inventory | 1.21 | 1.23 | 1.22 | 0.83 | 2.05 | Upgrade
|
| Prepaid Expenses | 0.54 | 0.59 | 0.39 | 0.58 | 0.63 | Upgrade
|
| Restricted Cash | - | - | - | 0.25 | 0.6 | Upgrade
|
| Other Current Assets | 0.02 | 0.02 | 0.68 | 3.16 | 0.05 | Upgrade
|
| Total Current Assets | 11.77 | 10.42 | 12.15 | 12.17 | 14.12 | Upgrade
|
| Property, Plant & Equipment | 2.97 | 2.65 | 2.92 | 1.6 | 11.73 | Upgrade
|
| Goodwill | - | - | - | - | 8.43 | Upgrade
|
| Other Intangible Assets | - | - | 0.86 | 2.13 | 11.35 | Upgrade
|
| Other Long-Term Assets | 0.05 | 0.05 | 0.05 | 22.53 | 0.04 | Upgrade
|
| Total Assets | 14.79 | 13.12 | 15.98 | 38.43 | 45.68 | Upgrade
|
| Accounts Payable | 1.66 | 1.54 | 1.05 | 1.37 | 4.51 | Upgrade
|
| Accrued Expenses | 3.33 | 3.01 | 7.9 | 9.04 | 8.34 | Upgrade
|
| Current Portion of Long-Term Debt | 4.29 | 5.1 | 2.5 | - | - | Upgrade
|
| Current Portion of Leases | 0.38 | 0.38 | 0.58 | 0.76 | 1.2 | Upgrade
|
| Current Income Taxes Payable | 0.26 | 0.26 | 0.26 | 0.22 | 0.33 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 0.05 | Upgrade
|
| Other Current Liabilities | 0.7 | 1.15 | 1.99 | 4.28 | 3.8 | Upgrade
|
| Total Current Liabilities | 10.62 | 11.44 | 14.28 | 15.68 | 18.23 | Upgrade
|
| Long-Term Debt | - | 4.24 | 11.17 | 9.44 | - | Upgrade
|
| Long-Term Leases | 1.18 | 1.47 | 1.85 | 0.52 | 3.54 | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | - | 0.14 | Upgrade
|
| Other Long-Term Liabilities | 5.21 | 4.97 | 5.22 | 8.67 | 6.32 | Upgrade
|
| Total Liabilities | 17.01 | 22.12 | 32.52 | 34.31 | 28.23 | Upgrade
|
| Common Stock | 0.41 | 0.41 | 0.41 | 0.4 | 0.4 | Upgrade
|
| Additional Paid-In Capital | 234.81 | 188.15 | 187.52 | 186.11 | 184.4 | Upgrade
|
| Retained Earnings | -235.38 | -242.08 | -249.02 | -227.06 | -212.12 | Upgrade
|
| Treasury Stock | -2.05 | -2.01 | -1.98 | -1.87 | -1.77 | Upgrade
|
| Total Common Equity | -2.22 | -55.54 | -63.07 | -42.42 | -29.08 | Upgrade
|
| Shareholders' Equity | -2.22 | -9 | -16.54 | 4.12 | 17.45 | Upgrade
|
| Total Liabilities & Equity | 14.79 | 13.12 | 15.98 | 38.43 | 45.68 | Upgrade
|
| Total Debt | 5.86 | 11.19 | 16.09 | 10.72 | 4.74 | Upgrade
|
| Net Cash (Debt) | -4.4 | -7.69 | -11.26 | -8.05 | -1.97 | Upgrade
|
| Net Cash Per Share | -0.28 | -1.76 | -2.66 | -1.95 | -0.49 | Upgrade
|
| Filing Date Shares Outstanding | 4.42 | 4.38 | 4.31 | 4.23 | 4.11 | Upgrade
|
| Total Common Shares Outstanding | 4.41 | 4.35 | 4.3 | 4.2 | 4.06 | Upgrade
|
| Working Capital | 1.16 | -1.02 | -2.13 | -3.52 | -4.11 | Upgrade
|
| Book Value Per Share | -0.50 | -12.76 | -14.68 | -10.11 | -7.17 | Upgrade
|
| Tangible Book Value | -2.22 | -55.54 | -63.93 | -44.55 | -48.87 | Upgrade
|
| Tangible Book Value Per Share | -0.50 | -12.76 | -14.88 | -10.62 | -12.05 | Upgrade
|
| Machinery | 3.47 | 2.81 | 2.55 | 2.22 | 8.21 | Upgrade
|
| Leasehold Improvements | 0.48 | 0.27 | 0.18 | 0.18 | 0.51 | Upgrade
|
Updated Nov 8, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.